![](jove-80-51304-thumb)

Introduction
============

Cell-free, *in vitro* transcription-translation reactions and the generation of vesicles from synthetic lipids are nothing new. However, combining the two into a cellular mimic is significantly more challenging1-6. *E. coli* cell extracts with or without T7 RNA polymerase can be used as a source of transcription-translation machinery^7,8^. Cell extracts benefit from the presence of additional cellular components that can facilitate protein expression and folding. Alternatively, a mix of individually purified RNA and protein molecules, *i.e.* the PURE system^9^, can be used to mediate intravesicular protein synthesis^4,10-14^. The PURE system allows for the construction of fully defined cellular mimics and does not suffer from the nuclease activity found in cell extracts. Practically, this means that much less DNA template is required, thereby facilitating processes with low encapsulation efficiency^11^. Although less frequently used, cellular mimics can be built with cell extracts derived from eukaryotic cells15. Thus far, genetically encoded encapsulated cascades and cellular mimics that sense the environment have been reported^16-18^.

The simplest way to monitor transcription-translation reactions is to measure the fluorescence or luminescence of genetically encoded elements. Typically, firefly luciferase^19 ^or GFP are used, although *in vitro* reactions are frequently measured by radiolabeling. Fluorescence detection additionally allows for the monitoring of populations of vesicles^20,21^ through cytometry based methods, thereby offering some insight into the stochastic nature of biological-like processes. These monitoring methods have been used to define a small set of design rules and a library of parts from which to build from, including a collection of fluorescent proteins that are compatible with *in vitro* transcription-translation^22^, the influence of genetic organization on expression^22,^ the activity of sigma factors^16^, and the efficiency of transcriptional terminators^23^. Nevertheless, there remains much that needs to be done to increase the capability of building predictable *in vitro*, genetically encoded devices.

There are many methods available to make vesicles. The most common methods depend upon the generation of a thin lipid film on a glass surface followed by resuspension in aqueous solution24. If the aqueous solution contains transcription-translation machinery, for example, then a fraction of the vesicles formed would contain the necessary components for protein production. However, the encapsulation efficiency of such methods is low, meaning that only a small percentage of vesicles are active. Many of the alternative methods characterized by much higher encapsulation efficiency exploit the conversion of water-in-oil emulsion droplets to vesicles. While it is likely that such methods will be commonplace in the future, currently these methods suffer from the need of specialized equipment and give vesicles with altered membrane compositions^25^. A distinct advantage of water-in-oil to vesicle methods is the potential to control membrane lamellarity. The method described herein is based on the thin lipid film protocol described by the Yomo laboratory^11 ^with slight modifications including an additional homogenization step. This method is easy, cheap, and gives robust vesicles well suited for the encapsulation of transcription-translation machinery.

Protocol
========

1. Preparing the DNA Template
-----------------------------

1.  Purify plasmid from a standard laboratory strain of *E. coli*, such as *E. coli* DH5a or Nova Blue with a commercial kit. Alternatively, a linear PCR product can be similarly purified with a commercial kit. Elute the DNA with H~2~O only.

2.  Phenol-chloroform extract the DNA solution^26^.

3.  Determine the DNA concentration and purity, *e.g.* by UV absorbance or other suitable methods. It is important to use highly pure DNA for efficient transcription-translation.

2. Preparing the Thin Lipid Film
--------------------------------

1.  Weigh the dry lipid powder and dissolve in solvent. For 1-palmitoyl-2-oleoyl-*sn*-glycero-3-phosphocholine (POPC), stock solutions are prepared in chloroform at a concentration of 40 mg/ml. Note: Organic solvents must always be handled with glass pipettes and bottles. In other words, plastic must never be used. Store stock solutions in air tight, solvent resistant amber glass bottles at -20 °C, preferably under argon.

2.  Aliquot 12 μmol POPC (220 μl of 40 mg/ml stock solution) into a 5 ml round bottom flask.

3.  Evaporate the solvent with a rotary evaporator (**Figure 1**) to generate the thin lipid film. Securely attach the round bottom flask to the distillation tube with a circular clip and start the rotation of the flask.Initiate the circulation of water through the condenser coil. Using a heat bath is not necessary, because chloroform has a low boiling point of 61.2 °C at normal atmospheric pressure.Ensure that the system is open to the atmosphere by checking that the stopcock is open. Turn on the vacuum pump and slowly close the stopcock to apply the vacuum to the system.A thin lipid film is deposited on the walls of the round bottom flask during rotary evaporation forming an opaque film that is visible by eye. Let the rotary evaporation continue for 0.5-2 hr. To stop the process, slowly release the vacuum pressure, stop the rotation, and remove the round bottom flask.

3. Lipid Resuspension and Vesicle Homogenization
------------------------------------------------

1.  Add 1 ml 18.2 MΩ H~2~O to the thin lipid film directly in the round bottom flask. Vigorously vortex the solution at maximum speed, approximately 3,200 rpm, until the lipid film detaches from the glass, which is observable by eye.

2.  Transfer the lipid dispersion into a 2 ml microcentrifuge tube.

3.  Set-up a ring stand to hold a homogenizer with a 5 mm tip. Place a microcentrifuge stand below the homogenizer to securely hold the lipid dispersion. Rinse the dispersing element of the homogenizer by immersing the tip in 18.2 MΩ H~2~O and running for a few seconds.

4.  Place the dispersing element directly into the lipid dispersion ensuring that the tip does not touch the bottom of the microcentrifuge tube. Homogenize for 1 min at power level 4 or 14,000 rpm.

4. Vesicle Extrusion and Lyophilization
---------------------------------------

1.  Assemble the parts of the mini-extruder (**Figure 2**), which consists of an outer casing and a retainer nut that houses two Teflon internal membrane supports, two O-rings, and one Teflon bearing. Place the two O-rings into the grooves of the internal membrane supports. Prewet two filters and one 400 nm membrane. The filters will be placed against the Teflon inside of the O-rings with the membrane between them.Place the membrane supports into the extruder outer casing with the membrane surrounded by two filters in between the O-rings. Place the Teflon bearing inside the casing and attach the retainer nut and tighten by hand.

2.  Rinse two syringes and fill one with 18.2 MΩ water. Insert the syringe needles into the small holes in the Teflon on either end of the extruder assembly. The needles should slide in easily; do not force the needles. Secure the extruder with the syringes into the extruder housing and fasten.

3.  Pass the water through the extruder by slowly pushing the water out of one syringe and into the other. This represents one passage. Repeat for a total of three passages ensuring that there are no leaks present. Remove the syringe of water and dispose of the water.

4.  Fill one syringe with the sample, attach to the extruder, and slowly pass the vesicle solution through the membrane as described above in step 4.3. Repeat 10x for a total of 11 passages. As the extrusion process proceeds, the sample will become less turbid and easier to push across the membrane. A sudden decrease in resistance, however, usually indicates a rupturing of the membrane.

5.  Transfer the extruded vesicle solution and make 40 μl aliquots of the vesicles into microcentrifuge tubes. Flash freeze each aliquot in either dry ice or in liquid nitrogen.

6.  Lyophilize each aliquot with a centrifugal evaporator overnight at 30 °C. Store the lyophilized empty vesicles at -20 °C.

5. Encapsulating Transcription-translation Machinery
----------------------------------------------------

1.  Mix the components of the transcription-translation reaction and add 20 units of RNase inhibitor. Incubate on ice.

2.  Add the DNA template. For a control reaction, 250 ng of a plasmid encoding mVenus or a similar fluorescent protein behind a T7 transcriptional promoter and a strong *E. coli* ribosome binding site is recommended.

3.  Bring the final volume to 25 μl with RNase-free water.

4.  Hydrate an aliquot of lyophilized vesicles (from step 4.6) with 10 μl of the reaction assembled in step 5.3. Briefly vortex the mixture until the vesicles are resuspended. This should take less than 30 sec.

5.  Incubate the reaction on ice for 30 min to allow the vesicles to swell.

6.  Dilute the vesicle mixture 20-fold to a final volume of 30 μl by adding 1.5 μl of vesicles into 27.0 μl of 50 mM Tris-HCl, 50 mM NaCl, pH 7.4 and 1.5 μl of 20.2 mg/ml Proteinase K. DNase and RNase can also be added at this point as an alternative to proteinase K to degrade extravesicular material.

7.  Incubate for at least 2.5 hr at 37 °C.

6. Microscopy
-------------

1.  Examine the vesicles and the progress of fluorescent protein production at different time points. The vesicles will have a larger diameter than the 400 nm pore-size of the membrane used for vesicle extrusion. Prepare a sample chamber by placing a 20 x 5 mm silicon spacer onto a standard microscope slide. Pipette 10 μl of vesicles into the sample chamber. Place a siliconized glass cover slip over the chamber.Observe the vesicles with a 63X oil-dispersion or similar objective by bright field and fluorescence microscopy using the appropriate filter set for the exploited fluorescent protein.

Representative Results
======================

Fluorescence microscopy reveals that fluorescence is only observed inside of the vesicles, because extravesicular material is enzymatically degraded (**Figure 3**). For the expression of mVenus, intravesicular fluorescence begins to be observed after 1.5 hr at 37 °C and reaches maximum fluorescence intensity within 6 hr. The optimal temperature and incubation time can vary depending upon the specific constructs used. For example, different fluorescent proteins mature quite differently in a temperature dependent manner. In other words, the observation of protein production is not solely dependent upon protein synthesis and folding but also on chromophore formation. Overall protein synthesis can be increased by incorporating membrane protein pores to allow for an influx of depleted components necessary for transcription and translation^27^.

It is recommended to carry out an analogous transcription-translation reaction in the absence of vesicles to ensure that the exploited genetic construct is functional. This control reaction is more easily monitored by fluorescence spectroscopy rather than microscopy. **Figure 4** shows an *in vitro* transcription-translation reaction of a construct encoding mVenus. Unencapsulated reactions give much higher total fluorescence intensities than similar intravesicular reactions. This is due to encapsulation efficiency and because the total intravesicular volume is much less than the extravesicular volume (*i.e.* a dilution effect).

**Figure 1. The rotary evaporator and vacuum pump**. [Click here to view larger image](http://www.jove.com/files/ftp_upload/51304/51304fig1highres.jpg).

**Figure 2.The housing and parts of the extruder are shown separately**. From left to right, syringe, retainer nut, teflon bearing, internal membrane supports with black O-rings facing one another, extruder outer casing, and second syringe. [Click here to view larger image](http://www.jove.com/files/ftp_upload/51304/51304fig2highres.jpg).

**Figure 3.Fluorescence images of mVenus protein production in liposomes**.** A** and** C:** Bright field images of multilamellar vesicles after 1.5 hr and 2.5 hr.** B** and** D:** The production of mVenus is visualized by fluorescence (colored green) after 1.5 and 2.5 hr, respectively. Scale bar is 20 μm. [Click here to view larger image](http://www.jove.com/files/ftp_upload/51304/51304fig3highres.jpg).

**Figure 4. *In vitro* control reaction of nonencapsulated *in vitro* transcription and translation of mVenus**. Fluorescence intensity was measured every 5 min over 4 hr. The data were acquired with a Real-Time PCR instrument. [Click here to view larger image](http://www.jove.com/files/ftp_upload/51304/51304fig4highres.jpg).

Discussion
==========

Although cell-free synthetic biology is still in its infancy, advances have laid a foundation from which increasingly complex cell-like systems can be made. The reconstitution of transcription-translation machinery from fully defined components^9 ^inside of vesicles^28 ^was particularly significant in facilitating later efforts in constructing environmentally responsive artificial cells17,18. Similarly, artificial cell studies have been used to probe evolutionary processes^4,29,30^, the mechanistic details of RNA and protein synthesis^22,31^, the influences of metabolic load32,33, and the assembly of viral particles^34^. Importantly, enough knowledge now exists that basic cellular function can be reconstituted inside of vesicles in the laboratory following these previous reports and the protocols described herein.

In addition to being easy, the described encapsulation procedure has several benefits. For example, many empty, lyophilized vesicle aliquots can be made in advance and stored at -20 °C for later use. The protocol does not subject biological molecules to organic solvents, drastic temperature changes, or long periods of dialysis. We expect that the gentleness of the procedure will facilitate the incorporation of additional components as needed. We also have not observed adverse effects to changing the lipid composition of the membrane on encapsulation or transcription-translation efficiency. Therefore, lipids more amenable to the incorporation of membrane proteins, specific morphologies, or visualization could conceivably be exploited.

The major limitation of the described method is that the resulting vesicles are not homogenous in size or lamellarity. For many applications, these difficulties do not interfere with the interpretation of data. However, if needed, additional steps can be incorporated to narrow the size distribution and decrease the layers of membranes, such as further rounds of extrusion after encapsulation, freeze-thawing, or dialysis^35^. Undoubtedly better methods that circumvent these and other problems will be developed. Until then, we find the protocol described here to be well suited for the construction of cellular mimics.
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